PRRT2 (Q7Z6L0) variants and mutations
PRRT2 (also known as Q7Z6L0) is a human protein-coding gene encoding a proline-rich transmembrane protein 2 protein. It modulates presynaptic neurotransmitter release and neuronal excitability through interactions with SNARE machinery and ion channels. Haploinsufficiency commonly causes paroxysmal kinesigenic dyskinesia, self-limited infantile seizures, or the combined infantile-convulsions-and-choreoathetosis phenotype. This analysis covers 980 PRRT2 variants and mutations. Of these, 82% have computational variant effect predictions. Disease context includes episodic kinesigenic dyskinesia 1, infantile convulsions and choreoathetosis, and benign familial infantile epilepsy. Example PRRT2 variants include A2E, A2T, and A3G.
Variant analysis overview
- Gene: PRRT2
- Protein: Q7Z6L0
- UniProt accession: Q7Z6L0
- Organism: Homo sapiens
- Variants analyzed: 980
- Variant scope: all variants
- Completed: 2026-08-18
Variant and mutation evidence
- Variant composition: 633 unspecified-consequence records; 151 missense variants; 158 synonymous variants; 8 in-frame deletions; 17 frameshift variants; 4 stop-gained variants; 2 in-frame insertions; 1 stop lost; 1 stop retained variant; 5 substitution
- Prediction scores: 803 variants have prediction scores (82% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: episodic kinesigenic dyskinesia 1, infantile convulsions and choreoathetosis, benign familial infantile epilepsy, episodic kinesigenic dyskinesia, hereditary disease, Seizure, PRRT2-associated paroxysmal movement disorder, neurodegenerative disease, autosomal recessive non-syndromic intellectual disability, Paroxysmal exertion-induced dyskinesia, familial or sporadic hemiplegic migraine, paroxysmal nonkinesigenic dyskinesia.
Protein structure and variant hotspots
- Protein features: 1 transmembrane segments; 6 post-translational modification sites.
- Structural context: 48 variants have structural context.
- PTM context: 17 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable PRRT2 variants
Examples include A2E, A2T, A3G, A3V, A3D, S4G, S4R, S4S. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- A2E (p.Ala2Glu), rs776704621, ClinGen CA7994459, ClinVar RCV003758285, ExAC rs776704621, REVEL 0.30, CADD 24.80, Uncertain significance, Episodic kinesigenic dyskinesia
- A2T (p.Ala2Thr), TOPMed rs1900055803, REVEL 0.29, CADD 25.50
- A3G (p.Ala3Gly), rs1555502548, ClinGen CA395476977, ClinVar RCV001234649, ClinVar RCV005000083, REVEL 0.10, CADD 23.00, Uncertain significance, not provided; Episodic kinesigenic dyskinesia
- A3V (p.Ala3Val), cosmic curated COSV54882, REVEL 0.05, CADD 23.20
- A3D (p.Ala3Asp), gnomAD 16-29813062-C-A, REVEL 0.13, CADD 24.80
- S4G (p.Ser4Gly), gnomAD rs1257121924, REVEL 0.09, CADD 24.50
- S4R (p.Ser4Arg), rs757148846, ClinGen CA7994460, ClinVar RCV001897266, ExAC rs757148846, REVEL 0.13, CADD 21.70, Uncertain significance, Episodic kinesigenic dyskinesia
- S4S (p.Ser4Ser), rs757148846, gnomAD 16-29813066-C-T, CADD 8.30
- S5N (p.Ser5Asn), ExAC rs745742339, TOPMed rs745742339, REVEL 0.12, CADD 15.80, Uncertain significance
- S5T (p.Ser5Thr), rs745742339, ClinGen CA317017, ClinVar RCV000467192, ExAC rs745742339, REVEL 0.12, CADD 10.70, Uncertain significance, Episodic kinesigenic dyskinesia
- S5S (p.Ser5Ser), rs2142421996, gnomAD 16-29813069-C-T, CADD 7.72
- S6F (p.Ser6Phe), rs2543330649, ClinGen CA395476996, ClinVar RCV003761169, ClinVar RCV005602084, Uncertain significance, not provided; Episodic kinesigenic dyskinesia
- S6L (p.Ser6Leu), gnomAD 16-29813070-TC-T, CADD 23.00
- S6P (p.Ser6Pro), gnomAD 16-29813070-T-C, REVEL 0.24, CADD 19.30
- S6S (p.Ser6Ser), gnomAD 16-29813072-T-C, CADD 5.23
- E7K (p.Glu7Lys), rs1215479164, ClinGen CA395476998, ClinVar RCV001870172, TOPMed rs1215479164, REVEL 0.08, CADD 19.60, Uncertain significance, Episodic kinesigenic dyskinesia
- E7Q (p.Glu7Gln), gnomAD 16-29813073-G-C, REVEL 0.04, CADD 17.40
- E7A (p.Glu7Ala), gnomAD 16-29813074-A-C, REVEL 0.15, CADD 24.00
- E7E (p.Glu7Glu), gnomAD 16-29813075-G-A, CADD 7.80
- E7D (p.Glu7Asp), gnomAD 16-29813075-G-T, REVEL 0.06, CADD 23.20
- I8T (p.Ile8Thr), Ensembl rs1900056922, REVEL 0.09, CADD 12.80
- p.Ile8 Glu10del, gnomAD 16-29813068-GCTCT, CADD 15.60
- I8F (p.Ile8Phe), gnomAD 16-29813076-A-T, REVEL 0.08, CADD 14.40
- I8I (p.Ile8Ile), gnomAD 16-29813078-C-A, CADD 7.68
- S9F (p.Ser9Phe), cosmic curated COSV10609
- S9P (p.Ser9Pro), ExAC rs749879243, gnomAD rs749879243
- S9T (p.Ser9Thr), rs749879243, ExAC rs749879243, gnomAD rs749879243, REVEL 0.17, CADD 13.40, Variant assessed as somatic; moderate impact.
- S9S (p.Ser9Ser), rs1596889747, gnomAD 16-29813081-T-G, CADD 7.37
- E10* (p.Glu10Ter), rs1900057283, ClinGen CA1139664638, ClinVar RCV001092087, ClinVar RCV003594091, Pathogenic
- E10K (p.Glu10Lys), 1000Genomes rs529418384, ExAC rs529418384, gnomAD rs529418384, REVEL 0.28, CADD 24.20
- E10Q (p.Glu10Gln), NCI-TCGA Cosmic COSV5488, cosmic curated COSV54886, Variant assessed as somatic; moderate impact.
- E10V (p.Glu10Val), rs2543330753, ClinGen CA395477021, ClinVar RCV003760093, Uncertain significance, Episodic kinesigenic dyskinesia
- M11I (p.Met11Ile), TOPMed rs1324649260, gnomAD rs1324649260, NCI-TCGA TCGA novel, REVEL 0.11, CADD 11.70, Variant assessed as somatic; moderate impact.
- M11L (p.Met11Leu), rs746699261, ClinGen CA395477024, ClinVar RCV002588220, ExAC rs746699261, REVEL 0.13, CADD 19.10, Uncertain significance, Episodic kinesigenic dyskinesia
- M11R (p.Met11Arg), rs796052942, ClinGen CA317046, ClinVar RCV000188781, TOPMed rs796052942, AlphaMissense 0.45, MetaLR 0.22, Uncertain significance, not provided
- M11T (p.Met11Thr), rs796052942, ClinGen CA395477027, ClinVar RCV001230081, ClinVar RCV005262316, REVEL 0.12, AlphaMissense 0.45, Uncertain significance, Episodic kinesigenic dyskinesia; Inborn genetic diseases
- K12E (p.Lys12Glu), rs2543330786, ClinGen CA395477032, ClinVar RCV002618518, Uncertain significance, Episodic kinesigenic dyskinesia
- K12M (p.Lys12Met), gnomAD 16-29813089-A-T, REVEL 0.29, CADD 24.10
- G13E (p.Gly13Glu), rs2543330836, ClinGen CA395477041, ClinVar RCV003759542, REVEL 0.11, CADD 5.83, Uncertain significance, Episodic kinesigenic dyskinesia
- G13R (p.Gly13Arg), rs770164221, ExAC rs770164221, gnomAD rs770164221, ClinGen CA395477040, REVEL 0.11, CADD 14.40, Likely benign, Episodic kinesigenic dyskinesia
- G13G (p.Gly13Gly), rs2142422128, gnomAD 16-29813093-G-A, CADD 7.46
- V14A (p.Val14Ala), gnomAD rs1425079924, REVEL 0.05, CADD 12.30, Uncertain significance, Episodic kinesigenic dyskinesia
- V14I (p.Val14Ile), rs1304660738, ClinGen CA395477046, ClinVar RCV002966701, TOPMed rs1304660738, REVEL 0.06, CADD 4.18, Uncertain significance, Episodic kinesigenic dyskinesia
- V14L (p.Val14Leu), TOPMed rs1304660738, gnomAD rs1304660738, REVEL 0.05, CADD 5.86, Uncertain significance
- E15K (p.Glu15Lys), rs1900058315, ClinGen CA395477050, ClinVar RCV002667500, ClinVar RCV004774712, REVEL 0.07, CADD 15.40, Uncertain significance, Episodic kinesigenic dyskinesia; not provided
- E15E (p.Glu15Glu), rs1900058431, gnomAD 16-29813099-G-A, CADD 2.16
- E16* (p.Glu16Ter), rs777959783, ClinGen CA395477059, ClinVar RCV003232633, AlphaMissense 0.10, MetaLR 0.19, Pathogenic
- E16D (p.Glu16Asp), ExAC rs749690425, TOPMed rs749690425, gnomAD rs749690425, REVEL 0.03, CADD 8.80
- E16G (p.Glu16Gly), rs1900058666, ClinGen CA395477061, ClinVar RCV001566617, ClinVar RCV006467697, REVEL 0.07, CADD 23.00, Uncertain significance, Episodic kinesigenic dyskinesia; not provided
- E16K (p.Glu16Lys), rs777959783, ClinGen CA7994467, ClinVar RCV001069135, ExAC rs777959783, REVEL 0.02, AlphaMissense 0.10, Uncertain significance, Episodic kinesigenic dyskinesia
- E16Q (p.Glu16Gln), rs777959783, ClinGen CA395477058, ClinVar RCV001890232, ExAC rs777959783, AlphaMissense 0.10, MetaLR 0.19, Uncertain significance, Episodic kinesigenic dyskinesia
- S17N (p.Ser17Asn), gnomAD 16-29813104-G-A, REVEL 0.06, CADD 13.50
- P18T (p.Pro18Thr), rs771505810, ClinGen CA7994469, ClinVar RCV002344578, ClinVar RCV003096687, REVEL 0.07, CADD 19.80, Uncertain significance, Inborn genetic diseases; Episodic kinesigenic dyskinesia
- K19* (p.Lys19Ter), rs775000504, ClinGen CA395477096, ClinVar RCV003594584, AlphaMissense 0.09, MetaLR 0.07, Pathogenic
- K19E (p.Lys19Glu), ExAC rs775000504, gnomAD rs775000504, REVEL 0.04, AlphaMissense 0.09, Uncertain significance
- K19N (p.Lys19Asn), ExAC rs759681485, TOPMed rs759681485, gnomAD rs759681485, REVEL 0.03, CADD 15.40
- K19Q (p.Lys19Gln), rs775000504, ClinGen CA7994470, ClinVar RCV001228756, ExAC rs775000504, REVEL 0.04, AlphaMissense 0.09, Likely benign, Episodic kinesigenic dyskinesia
- p.Lys19 Glu23del, gnomAD 16-29813107-CCAAG, CADD 12.20
- K19K (p.Lys19Lys), gnomAD 16-29813111-G-A, CADD 2.56
- V20F (p.Val20Phe), Ensembl rs1900059334
- V20I (p.Val20Ile), rs1900059334, ClinGen CA395477107, ClinVar RCV002592314, AlphaMissense 0.10, MetaLR 0.13, Uncertain significance, Episodic kinesigenic dyskinesia
- P21A (p.Pro21Ala), TOPMed rs1394325988, gnomAD rs1394325988, REVEL 0.06, CADD 14.50
- P21S (p.Pro21Ser), cosmic curated COSV54881, TOPMed rs1394325988, gnomAD rs1394325988, REVEL 0.06, CADD 15.80
- P21L (p.Pro21Leu), gnomAD 16-29813116-C-T, REVEL 0.04, CADD 14.80
- G22D (p.Gly22Asp), rs1385761586, ClinGen CA395477137, ClinVar RCV003848762, TOPMed rs1385761586, REVEL 0.18, CADD 20.10, Uncertain significance, Episodic kinesigenic dyskinesia
- G22S (p.Gly22Ser), rs1900059601, ClinGen CA395477132, ClinVar RCV002040621, ClinVar RCV003987956, REVEL 0.06, CADD 14.40, Uncertain significance, Episodic kinesigenic dyskinesia; Inborn genetic diseases; not specified
- G22G (p.Gly22Gly), rs775756146, gnomAD 16-29813120-C-T, CADD 1.47
- E23K (p.Glu23Lys), rs140383655, ClinGen CA231418, cosmic curated COSV99569, ClinVar RCV000118066, REVEL 0.06, CADD 13.00, Conflicting interpretations, Seizures, benign familial infantile, 2; Episodic kinesigenic dyskinesia 1; Infan
- G24E (p.Gly24Glu), rs201267591, ClinGen CA280409031, ClinVar RCV003067021, ClinVar RCV004960959, REVEL 0.23, CADD 20.30, Uncertain significance, Inborn genetic diseases; not provided; Episodic kinesigenic dyskinesia
- G24R (p.Gly24Arg), gnomAD 16-29813124-G-A, REVEL 0.21, CADD 22.60
- G24G (p.Gly24Gly), gnomAD 16-29813126-G-T, CADD 5.99
- P25A (p.Pro25Ala), ESP rs371883992, TOPMed rs371883992, REVEL 0.05, CADD 5.24
- P25L (p.Pro25Leu), rs1267727472, ClinGen CA395477171, ClinVar RCV003759213, CADD 13.80, Uncertain significance, Episodic kinesigenic dyskinesia
- P25R (p.Pro25Arg), rs1267727472, ClinGen CA395477169, ClinVar RCV003593658, TOPMed rs1267727472, CADD 14.20, Uncertain significance, Episodic kinesigenic dyskinesia
- P25T (p.Pro25Thr), cosmic curated COSV54886, CADD 15.70
- G26A (p.Gly26Ala), rs1227681764, ClinGen CA395477179, ClinVar RCV001840845, TOPMed rs1227681764, REVEL 0.11, CADD 19.60, Uncertain significance, not provided
- G26C (p.Gly26Cys), rs2142422369, ClinGen CA395477177, ClinVar RCV001955685, Ensembl rs2142422369, REVEL 0.14, CADD 18.70, Uncertain significance, Episodic kinesigenic dyskinesia
- H27P (p.His27Pro), ESP rs375779452, TOPMed rs375779452, Uncertain significance, not provided
- H27Y (p.His27Tyr), gnomAD 16-29813133-C-T, REVEL 0.07, CADD 21.40
- S28C (p.Ser28Cys), rs1900061006, ClinGen CA395477207, ClinVar RCV001348313, Ensembl rs1900061006, AlphaMissense 0.12, MetaLR 0.28, Uncertain significance, Episodic kinesigenic dyskinesia
- S28P (p.Ser28Pro), rs1900060891, ClinGen CA395477201, ClinVar RCV001043752, Ensembl rs1900060891, AlphaMissense 0.08, MetaLR 0.16, Uncertain significance, Episodic kinesigenic dyskinesia
- E29* (p.Glu29Ter), rs1555502574, ClinGen CA395477213, ClinVar RCV000520994, TOPMed rs1555502574, AlphaMissense 0.08, MetaLR 0.22, Likely pathogenic
- E29K (p.Glu29Lys), rs1555502574, ClinGen CA395477211, ClinVar RCV000521537, ClinVar RCV000809721, REVEL 0.10, AlphaMissense 0.08, Uncertain significance, Episodic kinesigenic dyskinesia; not provided
- A30V (p.Ala30Val), gnomAD rs1277397064, REVEL 0.05, CADD 15.90
- A30A (p.Ala30Ala), gnomAD 16-29813144-T-C, CADD 8.32
- E31K (p.Glu31Lys), gnomAD 16-29813145-G-A, REVEL 0.03, CADD 13.70
- E31E (p.Glu31Glu), rs1315799003, gnomAD 16-29813147-A-G, CADD 8.66
- T32S (p.Thr32Ser), Ensembl rs1900061597
- T32T (p.Thr32Thr), gnomAD 16-29813150-T-C, CADD 7.23
- G33D (p.Gly33Asp), rs1900061718, ClinGen CA395477274, ClinVar RCV001878465, TOPMed rs1900061718, AlphaMissense 0.12, MetaLR 0.16, Uncertain significance, Episodic kinesigenic dyskinesia
- G33G (p.Gly33Gly), rs1235109136, gnomAD 16-29813153-C-G, CADD 7.31
- P34L (p.Pro34Leu), rs2543331223, ClinGen CA395477287, ClinVar RCV003758619, Uncertain significance, Episodic kinesigenic dyskinesia
- P34S (p.Pro34Ser), gnomAD rs1273764641, REVEL 0.08, CADD 20.10
- P34P (p.Pro34Pro), gnomAD 16-29813156-T-C, CADD 12.20
- P35S (p.Pro35Ser), cosmic curated COSV54886
- Q36H (p.Gln36His), rs764412207, ClinGen CA7994474, ClinVar RCV001298184, ExAC rs764412207, REVEL 0.21, CADD 18.70, Uncertain significance, Episodic kinesigenic dyskinesia
- Q36K (p.Gln36Lys), rs2543331243, ClinGen CA395477301, ClinVar RCV003760459, cosmic curated COSV99569, Uncertain significance, Episodic kinesigenic dyskinesia
- Q36Q (p.Gln36Gln), rs764412207, gnomAD 16-29813162-G-A, CADD 4.12
- V37A (p.Val37Ala), gnomAD 16-29813164-T-C, REVEL 0.11, CADD 4.92
- L38I (p.Leu38Ile), rs1208143772, ClinGen CA395477327, ClinVar RCV001987912, TOPMed rs1208143772, REVEL 0.04, CADD 14.60, Uncertain significance, Episodic kinesigenic dyskinesia
- L38P (p.Leu38Pro), cosmic curated COSV99570
- L38L (p.Leu38Leu), rs1208143772, gnomAD 16-29813166-C-T, CADD 8.19
- A39G (p.Ala39Gly), ExAC rs753529940, TOPMed rs753529940, gnomAD rs753529940, REVEL 0.16, CADD 23.60, Uncertain significance
- A39T (p.Ala39Thr), rs1263878099, ClinGen CA395477338, ClinVar RCV001034191, TOPMed rs1263878099, REVEL 0.14, CADD 17.20, Likely benign, Episodic kinesigenic dyskinesia
- A39V (p.Ala39Val), rs753529940, ClinGen CA395477347, ClinVar RCV003077378, ClinVar RCV003085430, REVEL 0.22, CADD 23.70, Uncertain significance, Inborn genetic diseases; Episodic kinesigenic dyskinesia
- G40E (p.Gly40Glu), gnomAD rs1421985271, REVEL 0.04, CADD 14.90, Uncertain significance, Episodic kinesigenic dyskinesia
- G40R (p.Gly40Arg), rs1193212149, ClinGen CA395477349, ClinVar RCV001347316, ClinVar RCV006377091, REVEL 0.04, CADD 22.10, Uncertain significance, Episodic kinesigenic dyskinesia; Inborn genetic diseases
- G40V (p.Gly40Val), gnomAD rs1421985271
- V41I (p.Val41Ile), ExAC rs761612540, gnomAD rs761612540, REVEL 0.06, CADD 14.20
- V41L (p.Val41Leu), gnomAD 16-29813175-G-T, REVEL 0.07, CADD 18.80
- V41A (p.Val41Ala), gnomAD 16-29813176-T-C, REVEL 0.06, CADD 5.64
- V41V (p.Val41Val), gnomAD 16-29813177-A-G, CADD 2.98
- P42L (p.Pro42Leu), rs1166053009, ClinGen CA395477376, ClinVar RCV000781986, ClinVar RCV000815756, REVEL 0.03, CADD 18.80, Uncertain significance, Inborn genetic diseases; Episodic kinesigenic dyskinesia
- P42Q (p.Pro42Gln), TOPMed rs1166053009, gnomAD rs1166053009, Uncertain significance
- P42S (p.Pro42Ser), rs1019859682, ClinGen CA280409049, ClinVar RCV003853174, TOPMed rs1019859682, REVEL 0.03, CADD 0.85, Uncertain significance, Episodic kinesigenic dyskinesia
- P42T (p.Pro42Thr), TOPMed rs1019859682, Uncertain significance
- P42A (p.Pro42Ala), gnomAD 16-29813178-C-G, REVEL 0.03, CADD 0.47
- D43A (p.Asp43Ala), Ensembl rs1596890089
- D43G (p.Asp43Gly), rs1596890089, ClinGen CA395477386, ClinVar RCV003058113, ClinVar RCV003448476, REVEL 0.10, CADD 9.22, Uncertain significance, Episodic kinesigenic dyskinesia 1; Episodic kinesigenic dyskinesia
- D43H (p.Asp43His), TOPMed rs1039026144
- D43N (p.Asp43Asn), TOPMed rs1039026144
- D43Y (p.Asp43Tyr), gnomAD 16-29813181-G-T, REVEL 0.18, CADD 22.60
- P45S (p.Pro45Ser), rs11556732, ClinGen CA317009, ClinVar RCV000188757, ClinVar RCV000514138, REVEL 0.12, CADD 23.10, Conflicting interpretations, Inborn genetic diseases; Episodic kinesigenic dyskinesia; not specified
- P45L (p.Pro45Leu), gnomAD 16-29813188-C-T, REVEL 0.15, CADD 23.80
- E46G (p.Glu46Gly), TOPMed rs1900064214
- E46K (p.Glu46Lys), rs1456787900, ClinGen CA395477422, ClinVar RCV002615767, gnomAD rs1456787900, REVEL 0.30, CADD 24.60, Uncertain significance, Episodic kinesigenic dyskinesia
- E46Q (p.Glu46Gln), gnomAD rs1456787900, REVEL 0.23, CADD 23.80, Uncertain significance
- E46E (p.Glu46Glu), rs1291344054, gnomAD 16-29813192-G-A, CADD 7.54
- A47S (p.Ala47Ser), ExAC rs750429521, gnomAD rs750429521, REVEL 0.07, CADD 11.50
- A47T (p.Ala47Thr), gnomAD 16-29813193-G-A, REVEL 0.04, CADD 10.40
- A47V (p.Ala47Val), gnomAD 16-29813194-C-T, REVEL 0.09, CADD 22.60
- P48L (p.Pro48Leu), rs539726929, ClinGen CA280409073, ClinVar RCV001361704, gnomAD rs539726929, REVEL 0.03, CADD 0.00, Uncertain significance, Episodic kinesigenic dyskinesia
- P48R (p.Pro48Arg), gnomAD rs539726929, Uncertain significance
- P48S (p.Pro48Ser), gnomAD rs1900064670, REVEL 0.03, CADD 4.73
- P48P (p.Pro48Pro), rs1192918667, gnomAD 16-29813198-G-A, CADD 3.25
- Q49E (p.Gln49Glu), rs2543331489, ClinGen CA395477460, ClinVar RCV003059492, ClinVar RCV004763516, Uncertain significance, not provided; Episodic kinesigenic dyskinesia
- Q49R (p.Gln49Arg), rs2543331497, ClinVar RCV004585855, Uncertain significance, not provided
- Q49Q (p.Gln49Gln), rs757890923, gnomAD 16-29813201-G-A, CADD 1.27
- P50A (p.Pro50Ala), ExAC rs779469716, gnomAD rs779469716, REVEL 0.04, CADD 9.11
- P50L (p.Pro50Leu), TOPMed rs1031799493
- P50T (p.Pro50Thr), gnomAD 16-29813202-C-A, REVEL 0.07, CADD 19.20
- G51A (p.Gly51Ala), gnomAD rs1474045415, REVEL 0.08, CADD 8.99
- G51C (p.Gly51Cys), ExAC rs751112065, gnomAD rs751112065, REVEL 0.13, CADD 23.50
- G51S (p.Gly51Ser), ExAC rs751112065, gnomAD rs751112065, REVEL 0.07, CADD 21.10
- G51D (p.Gly51Asp), gnomAD 16-29813206-G-A, REVEL 0.09, CADD 9.98
- P52A (p.Pro52Ala), gnomAD 16-29813208-C-G, REVEL 0.16, CADD 15.60
- P52S (p.Pro52Ser), gnomAD 16-29813208-C-T, REVEL 0.17, CADD 6.93
- P52P (p.Pro52Pro), gnomAD 16-29813210-A-G, CADD 8.47
- N53H (p.Asn53His), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- N53Y (p.Asn53Tyr), gnomAD rs1164379703, REVEL 0.08, CADD 22.30
- N53N (p.Asn53Asn), gnomAD 16-29813213-C-T, CADD 2.90
- T54S (p.Thr54Ser), rs2543331554, ClinGen CA395477526, ClinVar RCV002302927, REVEL 0.04, CADD 0.48, Uncertain significance, Episodic kinesigenic dyskinesia
- T55A (p.Thr55Ala), NCI-TCGA Cosmic COSV9956, cosmic curated COSV99569, Variant assessed as somatic; moderate impact.
- T55P (p.Thr55Pro), NCI-TCGA Cosmic COSV9956, Variant assessed as somatic; moderate impact.
- T55I (p.Thr55Ile), gnomAD 16-29813218-C-T, REVEL 0.04, CADD 0.76
- T55T (p.Thr55Thr), rs754536441, gnomAD 16-29813219-T-G, CADD 2.35
- A56V (p.Ala56Val), rs780909712, ClinGen CA7994482, ClinVar RCV001235545, ClinVar RCV001664772, REVEL 0.08, CADD 3.27, Conflicting interpretations, Episodic kinesigenic dyskinesia; not provided
- A56S (p.Ala56Ser), gnomAD 16-29813220-G-T, REVEL 0.05, CADD 10.70
- A56A (p.Ala56Ala), gnomAD 16-29813222-G-C, CADD 2.47
- A57D (p.Ala57Asp), rs1262636745, ClinGen CA395477545, ClinVar RCV001302598, gnomAD rs1262636745, REVEL 0.08, CADD 7.87, Uncertain significance, Episodic kinesigenic dyskinesia
- A57V (p.Ala57Val), rs1262636745, ClinGen CA395477547, ClinVar RCV003594831, gnomAD rs1262636745, REVEL 0.09, CADD 7.84, Uncertain significance, Episodic kinesigenic dyskinesia
- A57A (p.Ala57Ala), rs771487218, gnomAD 16-29813225-C-T, CADD 3.83
- P58A (p.Pro58Ala), 1000Genomes rs540005714, ExAC rs540005714, gnomAD rs540005714, REVEL 0.04, CADD 8.70, Uncertain significance, Inborn genetic diseases
- P58R (p.Pro58Arg), rs1567378768, ClinGen CA395477551, ClinVar RCV000678832, ClinVar RCV002232812, REVEL 0.20, CADD 16.40, Uncertain significance, Episodic kinesigenic dyskinesia
- P58S (p.Pro58Ser), rs540005714, ClinGen CA395477549, ClinVar RCV001992586, ClinVar RCV004728978, REVEL 0.04, CADD 6.50, Uncertain significance, Episodic kinesigenic dyskinesia; not specified; Inborn genetic diseases
- P58T (p.Pro58Thr), cosmic curated COSV99569
- V59E (p.Val59Glu), rs1900066714, ClinGen CA395477556, ClinVar RCV001247164, Ensembl rs1900066714, AlphaMissense 0.13, MetaLR 0.19, Uncertain significance, Episodic kinesigenic dyskinesia
- V59V (p.Val59Val), rs1261340987, gnomAD 16-29813231-G-A, CADD 6.27
- D60A (p.Asp60Ala), rs772163627, ClinGen CA7994487, ClinVar RCV001887862, ExAC rs772163627, REVEL 0.11, CADD 20.30, Uncertain significance, Episodic kinesigenic dyskinesia
- S61* (p.Ser61Ter), rs2142422901, ClinGen CA395477579, ClinVar RCV001726990, Ensembl rs2142422901, Pathogenic
- S61A (p.Ser61Ala), cosmic curated COSV10877
- S61S (p.Ser61Ser), rs775396962, gnomAD 16-29813237-A-G, CADD 4.42
- G62R (p.Gly62Arg), cosmic curated COSV54886, REVEL 0.08, CADD 17.40, Uncertain significance, Episodic kinesigenic dyskinesia
- G62V (p.Gly62Val), rs2543331706, ClinGen CA395477592, ClinVar RCV003758221, Uncertain significance, Episodic kinesigenic dyskinesia
- G62G (p.Gly62Gly), rs760833206, gnomAD 16-29813240-G-T, CADD 3.81
- P63T (p.Pro63Thr), TOPMed rs1189865310
- P63S (p.Pro63Ser), gnomAD 16-29813241-C-T, REVEL 0.14, CADD 8.10
- P63P (p.Pro63Pro), gnomAD 16-29813243-C-G, CADD 2.20
- K64K (p.Lys64Lys), rs1422649070, gnomAD 16-29813246-G-A, CADD 3.79
- A65G (p.Ala65Gly), rs768706409, ClinGen CA7994490, ClinVar RCV002866122, ExAC rs768706409, REVEL 0.03, CADD 22.00, Uncertain significance, Episodic kinesigenic dyskinesia
Public PRRT2 analysis runs
- PRRT2 analysis run — PRRT2 (980 variants) — completed 2026-08-18